Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report

A woman with systemic lupus erythematosus and Type 2 diabetes mellitus developed dermatomyositis, presenting with a worsening skin rash, muscle weakness, and scalp hair loss. Her condition deteriorated until she was bed-bound. After a skin and muscle biopsy confirmed dermatomyositis, treatment with rituximab resulted in improvements in creatine kinase levels and muscle strength, indicating its effectiveness over conventional therapy for her condition.